294 related articles for article (PubMed ID: 9798725)
21. Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity.
Poitout V; Robertson RP
Endocrinology; 2002 Feb; 143(2):339-42. PubMed ID: 11796484
[TBL] [Abstract][Full Text] [Related]
22. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
[TBL] [Abstract][Full Text] [Related]
23. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial metabolism reveals a functional architecture in intact islets of Langerhans from normal and diabetic Psammomys obesus.
Katzman SM; Messerli MA; Barry DT; Grossman A; Harel T; Wikstrom JD; Corkey BE; Smith PJ; Shirihai OS
Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1090-9. PubMed ID: 15339741
[TBL] [Abstract][Full Text] [Related]
25. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
26. Amino acid metabolism, insulin secretion and diabetes.
Newsholme P; Bender K; Kiely A; Brennan L
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1180-6. PubMed ID: 17956307
[TBL] [Abstract][Full Text] [Related]
27. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes.
Prentki M; Joly E; El-Assaad W; Roduit R
Diabetes; 2002 Dec; 51 Suppl 3():S405-13. PubMed ID: 12475783
[TBL] [Abstract][Full Text] [Related]
28. Atypical protein kinase C in glucose metabolism.
Liu XJ; He AB; Chang YS; Fang FD
Cell Signal; 2006 Dec; 18(12):2071-6. PubMed ID: 16787739
[TBL] [Abstract][Full Text] [Related]
29. Dysfunctional insulin secretion in type 2 diabetes: role of metabolic abnormalities.
Grill V; Björklund A
Cell Mol Life Sci; 2000 Mar; 57(3):429-40. PubMed ID: 10823244
[TBL] [Abstract][Full Text] [Related]
30. Lipid-associated metabolic signalling networks in pancreatic beta cell function.
Prentki M; Corkey BE; Madiraju SRM
Diabetologia; 2020 Jan; 63(1):10-20. PubMed ID: 31423551
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial function in normal and diabetic beta-cells.
Maechler P; Wollheim CB
Nature; 2001 Dec; 414(6865):807-12. PubMed ID: 11742413
[TBL] [Abstract][Full Text] [Related]
32. Beta-cell failure in the pathogenesis of type 2 diabetes mellitus.
Steppel JH; Horton ES
Curr Diab Rep; 2004 Jun; 4(3):169-75. PubMed ID: 15132880
[TBL] [Abstract][Full Text] [Related]
33. Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept.
Holz GG; Habener JF
Trends Biochem Sci; 1992 Oct; 17(10):388-93. PubMed ID: 1455507
[TBL] [Abstract][Full Text] [Related]
34. beta-cell biology in the 21st century.
Margolis R; Laughlin M; Haft CR
Trends Endocrinol Metab; 2002 Jul; 13(5):185-7. PubMed ID: 12185661
[No Abstract] [Full Text] [Related]
35. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion.
Leahy JL; Bonner-Weir S; Weir GC
Diabetes Care; 1992 Mar; 15(3):442-55. PubMed ID: 1559411
[TBL] [Abstract][Full Text] [Related]
36. Connecting pancreatic islet lipid metabolism with insulin secretion and the development of type 2 diabetes.
Imai Y; Cousins RS; Liu S; Phelps BM; Promes JA
Ann N Y Acad Sci; 2020 Feb; 1461(1):53-72. PubMed ID: 30937918
[TBL] [Abstract][Full Text] [Related]
37. Would R.D. Lawrence have been interested in the regulation of insulin secretion from pancreatic beta-cells?
Jones PM
Diabet Med; 1998 Aug; 15(8):644-50. PubMed ID: 9702466
[TBL] [Abstract][Full Text] [Related]
38. Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of Type 2 diabetes mellitus.
Holness MJ; Langdown ML; Sugden MC
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):657-65. PubMed ID: 10903125
[TBL] [Abstract][Full Text] [Related]
39. Deteriorating beta-cell function in type 2 diabetes: a long-term model.
Bagust A; Beale S
QJM; 2003 Apr; 96(4):281-8. PubMed ID: 12651972
[TBL] [Abstract][Full Text] [Related]
40. Gluco-lipotoxicity of the pancreatic beta cell.
Poitout V; Briaud I; Kelpe C; Hagman D
Ann Endocrinol (Paris); 2004 Feb; 65(1):37-41. PubMed ID: 15122090
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
